Cover Image

ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor

Abstract Background Opioid use disorder (OUD) poses a global health challenge, and despite medications for opioid use disorder (MOUD) and psychosocial interventions, relapse remains a significant concern. Comorbid psychiatric disorders, including attention deficit hyperactivity disorder (ADHD), are...

Full description

Saved in:

Bibliographic Details
Main Authors:	Auxane Beslot (Author), Marie Grall-Bronnec (Author), Marianne Balem (Author), Benoit Schreck (Author), Edouard-Jules Laforgue (Author), Caroline Victorri-Vigneau (Author), Morgane Guillou-Landreat (Author), Juliette Leboucher (Author), OPAL-Group (Author), Gaëlle Challet-Bouju (Author), Clémence Cabelguen (Author)
Format:	Book
Published:	BMC, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study
by: Morgane Guillou Landreat, et al.
Published: (2022)

"Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
by: Aurélie Aquizerate, et al.
Published: (2024)

Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey
by: Sarah Chaaban, et al.
Published: (2024)

Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data
by: Edouard-Jules Laforgue, et al.
Published: (2023)

Impact of alcohol marketing on drinkers with Alcohol use disorders seeking treatment: a mixed-method study protocol
by: Morgane Guillou-Landreat, et al.
Published: (2020)

Alcohol use disorders, beverage preferences and the influence of alcohol marketing: a preliminary study
by: Morgane Guillou Landreat, et al.
Published: (2020)

The efficacy of a targeted PREVENTION programme for addictive behaviour (PREVENTURE) among vulnerable ADOlescents in France - study procotol
by: morgane guillou-landreat, et al.
Published: (2021)

Editorial: Opioids and opioid-use disorders
by: Giordano de Guglielmo, et al.
Published: (2023)

Modeling Early Gambling Behavior Using Indicators from Online Lottery Gambling Tracking Data: Longitudinal Analysis
by: Challet-Bouju, Gaëlle, et al.
Published: (2020)

Identification and Treatment of Opioid Withdrawal and Opioid Use Disorder in the Emergency Department
by: Lindsey Jennings, et al.
Published: (2020)

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy
by: Cheetham A, et al.
Published: (2022)

Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
by: Jens Reimer, et al.
Published: (2019)

Editorial: Reviews in opioid use disorders
by: Wendy Walwyn, et al.
Published: (2024)

Primary care for opioid use disorder
by: Mannelli P, et al.
Published: (2016)

Naltrexone Implant for Opioid Use Disorder
by: Amber N. Edinoff, et al.
Published: (2021)

Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse
by: James A. Swartz, et al.
Published: (2023)

Stigmatization of Pregnant Individuals with Opioid Use Disorder
by: Allison D. Crawford, et al.
Published: (2022)

Opioid use disorder and treatment: challenges and opportunities
by: Kim A. Hoffman, et al.
Published: (2019)

Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
by: Disa Dahlman, et al.
Published: (2021)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017)

Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers
by: Joseph Goulet, et al.
Published: (2023)

Rising Racial Disparities in Opioid Mortality and Undertreatment of Opioid Use Disorder and Mental Health Comorbidities in Virginia
by: Jacqueline B. Britz, MD, MSPH, et al.
Published: (2023)

Addressing opioid use disorder: Mexico's step backwards
by: Steffanie A. Strathdee, et al.
Published: (2023)

Opioid use disorder: current trends and potential treatments
by: Yu Kyung Lee, et al.
Published: (2024)

Prescribers' satisfaction with delivering medications for opioid use disorder
by: Hannah K. Knudsen, et al.
Published: (2021)

Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders
by: Chloé Melchior, et al.
Published: (2020)

A Predictive Algorithm to Detect Opioid Use Disorder
by: Chee Lee, et al.
Published: (2018)

Opioid prescriber screening practices to detect risk for developing opioid use disorder: Qualitative perspectives from providers during the fourth wave of the opioid crisis
by: Margie R. Skeer, et al.
Published: (2023)

Nitrous oxide: a unique official French addictovigilance national survey
by: Marylène Guerlais, et al.
Published: (2023)

First results of the French OCTOPUS survey among festival attendees: a latent class analysis
by: Marion Istvan, et al.
Published: (2023)

Variation in intervention stigma among medications for opioid use disorder
by: Erin F. Madden, et al.
Published: (2022)

The effect of the COVID-19 pandemic on the prescribing of opioid and opioid use disorder medications within an academic medical center in California
by: Armen K. Fstkchian, et al.
Published: (2023)

Association Between Opioid Use Disorder and Seizure Incidents Among Alcohol Use Disorder Patients
by: Hiroko Furo, et al.
Published: (2023)

The MEOPAeDent trial protocol-an observational study of the Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) effects in paediatric dentistry
by: Tony Prud'homme, et al.
Published: (2019)

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023)

Information on doctor and pharmacy shopping for opioids adds little to the identification of presumptive opioid abuse disorders in health insurance claims data
by: Walker AM, et al.
Published: (2019)

Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population
by: Nicholas Alexander Bascou, et al.
Published: (2022)

Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder
by: Brenton A, et al.
Published: (2017)

Disclosure Patterns of Opioid Use Disorders in Perinatal Care During the Opioid Epidemic on X From 2019 to 2021: Thematic Analysis
by: Dezhi Wu, et al.
Published: (2024)

Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
by: Anne Berit Bech, et al.
Published: (2019)